(Q38047048)

27 August 2017

Negative regulation of myeloid-derived suppressor cells in cancer (English)

1 reference

27 August 2017

Peng Qu

1

1 reference

PubMed ID

23017135

27 August 2017

Kimberly C Boelte

series ordinal

2

1 reference

PubMed ID

23017135

27 August 2017

P Charles Lin

series ordinal

3

1 reference

27 August 2017

1 January 2012

1 reference

Immunological Investigations

27 August 2017

1 reference

27 August 2017

41

1 reference

27 August 2017

6-7

1 reference

27 August 2017

562-580

1 reference

Rgs2 mediates pro-angiogenic function of myeloid derived suppressor cells in the tumor microenvironment via upregulation of MCP-1.

27 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Characterization of the MDSC proteome associated with metastatic murine mammary tumors using label-free mass spectrometry and shotgun proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Sustained exposure to bacterial antigen induces interferon-γ-dependent T cell receptor ζ down-regulation and impaired T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

L-arginine metabolism in myeloid cells controls T-lymphocyte functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

MicroRNA-125b potentiates macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

TGF-beta promotes invasion and metastasis of gastric cancer cells by increasing fascin1 expression via ERK and JNK signal pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Myeloid-derived suppressor cells as regulators of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Myeloid derived suppressor cells in human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

CD49d is a new marker for distinct myeloid-derived suppressor cell subpopulations in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Regulation of progenitor cell proliferation and granulocyte function by microRNA-223

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

EP2, a receptor for PGE2, regulates tumor angiogenesis through direct effects on endothelial cell motility and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Targeting STAT3 in adoptively transferred T cells promotes their in vivo expansion and antitumor effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Myeloid derived suppressor cells in transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Role of immature myeloid Gr-1+ cells in the development of antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

C/EBP-δ regulates VEGF-C autocrine signaling in lymphangiogenesis and metastasis of lung cancer through HIF-1α.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Myeloid-derived suppressor cells in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Mechanism of T cell tolerance induced by myeloid-derived suppressor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Targeting of Jak/STAT pathway in antigen presenting cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

MicroRNA-155 is induced during the macrophage inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Myeloid-derived suppressor cells: linking inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Cyclophosphamide potentiates the antitumor effect of immunization with injection of immature dendritic cells into irradiated tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Myeloid-derived suppressor cell heterogeneity and subset definition.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Irradiated tumor cell vaccine for treatment of an established glioma. II. Expansion of myeloid suppressor cells that promote tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Myeloid-specific expression of Api6/AIM/Sp alpha induces systemic inflammation and adenocarcinoma in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Matrix metalloproteinase 12 overexpression in lung epithelial cells plays a key role in emphysema to lung bronchioalveolar adenocarcinoma transition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Myeloid-specific expression of human lysosomal acid lipase corrects malformation and malfunction of myeloid-derived suppressor cells in lal-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Matrix metalloproteinase 12 overexpression in myeloid lineage cells plays a key role in modulating myelopoiesis, immune suppression, and lung tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Derangement of immune responses by myeloid suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Altered macrophage differentiation and immune dysfunction in tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Subsets of myeloid-derived suppressor cells in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Tumor- and organ-dependent infiltration by myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Both miR-17-5p and miR-20a alleviate suppressive potential of myeloid-derived suppressor cells by modulating STAT3 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2012.685538

Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells

21 January 2018

1 reference

12 December 2020

Endotoxin-induced myeloid-derived suppressor cells inhibit alloimmune responses via heme oxygenase-1

1 reference

12 December 2020

Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression

1 reference

12 December 2020

Chemoprevention by cyclooxygenase-2 inhibition reduces immature myeloid suppressor cell expansion

1 reference

12 December 2020

Spleen but not tumor infiltration by dendritic and T cells is increased by intravenous adenovirus-Flt3 ligand injection

1 reference

12 December 2020

TCR zeta down-regulation under chronic inflammation is mediated by myeloid suppressor cells differentially distributed between various lymphatic organs

1 reference

12 December 2020

TGF-β1 promotes motility and invasiveness of glioma cells through activation of ADAM17.

1 reference

12 December 2020

STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion

1 reference

12 December 2020

microRNA regulation of inflammatory responses

1 reference

12 December 2020

CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis

1 reference

12 December 2020

In vivo induction of myeloid suppressor cells and CD4(+)Foxp3(+) T regulatory cells prolongs skin allograft survival in mice

1 reference

12 December 2020

Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cells

1 reference

12 December 2020

Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo

1 reference

12 December 2020

Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion

1 reference

12 December 2020

Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer

1 reference

12 December 2020

Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells.

1 reference

12 December 2020

Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response

1 reference

12 December 2020

Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation.

1 reference

12 December 2020

All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination.

1 reference

12 December 2020

Regulation of lymphocytes by nitric oxide

1 reference

12 December 2020

Mechanisms of tumor evasion from the immune response.

1 reference

12 December 2020

Myeloid-derived suppressor cells in inflammation: uncovering cell subsets with enhanced immunosuppressive functions

1 reference

12 December 2020

Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancer

1 reference

12 December 2020

10.3109/08820139.2012.685538

Identifiers

DOI

1 reference

27 August 2017

1 reference

PubMed ID

23017135